CYWC628 (Human Dermal Fibroblast Spheroids)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CYWC628 (Human Dermal Fibroblast Spheroids), covering 2025-07-31 to 2025-07-31. Get the full timeline:
Most recent: Clinical Trial Update: Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care [Phase 1, Phase 2]